---

---

published : Previous years    tags : Biotech-bay   

save search

---

Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
ACET | News | $2.1 5.0% 750K |

Health Technology

| 2.56% | O: 2.56% H: 2.0% C: 0.0%
adi-270 presentation cell preclinical for meeting therapy

---

Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
Published: 2024-04-22 (Crawled : 23:00) - biospace.com/
SPRB | News | $0.7053 1.92% 690K |

Health Technology

| -1.43% | O: -2.86% H: 2.94% C: 1.47%
presentation endocrine meeting

---

New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Published: 2024-04-22 (Crawled : 17:00) - biospace.com/
VCYT | News | $20.24 1.97% 210K |

Health Technology

| 2.06% | O: 1.03% H: 2.65% C: 1.02%
active test cancer for study

---

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
GH | News M | $17.675 0.48% 600K |

Health Services

| 9.46% | O: 4.42% H: 5.36% C: 4.83%
fda test review cancer blood for

---

Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
TWST | $31.34 6.42% 580K |

Health Technology

| 3.08% | O: -0.04% H: 0.0% C: 0.0%
report bioscience financial results

---

Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
Published: 2024-04-16 (Crawled : 00:00) - biospace.com/
EXEL | $23.37 2.19% 570K |

Health Technology

| 0.75% | O: -0.62% H: 0.0% C: 0.0%
first financial results

---

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
GIA | $1.08 237.96% 1.4K |

| Email alert Add to watchlist
breast technology trial imaging

---

Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
Published: 2024-04-15 (Crawled : 14:00) - biospace.com/
A | $137.89 3.02% 420K |

Health Technology

| -4.85% | O: 1.12% H: 0.66% C: -1.47%
certification assay for

---

Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
Published: 2024-04-15 (Crawled : 14:00) - biospace.com/
OM | $2.485 6.2% 230K |

Health Technology

| 14.15% | O: 0.0% H: 2.93% C: -0.49%
association care medical

---

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2024
Published: 2024-04-11 (Crawled : 07:00) - biospace.com/
MIRM | $24.665 2.05% 99K |

Health Technology

| -5.59% | O: -0.35% H: 1.98% C: 1.25%
nasdaq pharmaceuticals grants

---

Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Published: 2024-04-09 (Crawled : 14:30) - biospace.com/
VTGN | $4.93 3.14% 120K |

Health Technology

| -7.54% | O: 0.58% H: 3.65% C: 3.27%
conference association depression

---

Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 22:00) - biospace.com/
ACLX | $55.43 6.6% 160K |

| -17.72% | O: -0.13% H: 2.16% C: -1.76%
conference

---

Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
GH | News M | $17.675 0.48% 600K |

Health Services

| -15.39% | O: -0.14% H: 4.43% C: -5.11%
precision health meeting application

---

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
ANNX | $4.57 0.55% 170K |

Health Technology

| -29.28% | O: 0.78% H: 3.86% C: -0.31%
conference

---

Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
Published: 2024-04-03 (Crawled : 14:00) - biospace.com/
A | $137.89 3.02% 420K |

Health Technology

| -7.12% | O: -0.28% H: 0.75% C: -0.03%
cancer research diagnostics

---

Nurix Therapeutics to Participate in Upcoming Investor Conferences - April 03, 2024
Published: 2024-04-03 (Crawled : 12:00) - biospace.com/
NRIX 6 d | $14.27 5.08% 150K |

Health Technology

| -8.61% | O: -1.28% H: 0.68% C: -0.55%
therapeutics

---

Infinant Health Announces Submission of Orphan Drug Designation Application
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.575 0.31% 2.5M |

Health Technology

| -5.49% | O: -0.77% H: 0.8% C: 0.74%
drug health designation application submission

---

Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Published: 2024-04-02 (Crawled : 14:00) - biospace.com/
JAGX | News | $0.1572 -12.62% 23M |

Health Technology

| 133.77% | O: -4.68% H: 0.82% C: 0.82%
health international

---

Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
BMY | $49.35 0.43% 1.4M |

Health Technology

| -7.27% | O: 0.21% H: 0.47% C: -0.68%
report

---

Jaguar Health Reports 2023 Financial Results
Published: 2024-04-01 (Crawled : 18:00) - biospace.com/
JAGX | News | $0.1572 -12.62% 23M |

Health Technology

| 100.22% | O: 0.0% H: 0.0% C: -14.35%
health financial results

---

Gainers vs Losers

87%

13%

Top 10 Gainers

MTTR | News M | $4.595 164.08% 13M |

AGBA | $2.355 88.4% 34M |

Finance

EDBL | News | $6.75 79.52% 1.5M |

CZOO | $8.77 75.75% 11M |

MTC | $2.28 46.15% 2.6M |

Technology Services

OPRT | News | $3.14 39.56% 7.6M |

Finance

VNRX | $0.8 33.33% 2.9M |

Health Technology

MLEC | $1.865 33.21% 2.4M |

n/a

PALI | $6.37 29.21% 21M |

Manufacturing

CMAX | $4.12 28.35% 65K |

Manufacturing

---

Your saved searches

---